m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00729)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
DARS
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Liver | Mus musculus |
Treatment: Mettl3 knockout liver
Control: Wild type liver cells
|
GSE198513 | |
Regulation |
|
logFC: -5.90E-01 p-value: 7.45E-13 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between DARS and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 2.22E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | DARS-AS1 was validated to facilitate DARS translation via recruiting METTL3 and METTL14, which bound with DARS mRNA Aspartate--tRNA ligase, cytoplasmic (DARS) mRNA 5' untranslated region (5'UTR) and promoting its translation. The present study demonstrated that the 'HIF1-Alpha/DARS-AS1/DARS/ATG5/ATG3' pathway regulated the hypoxia-induced cytoprotective autophagy of cervical cancer(CC) and is a promising target of therapeutic strategies for patients afflicted with CC. | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Pathway Response | Autophagy | hsa04140 | ||
Cell Process | Cell autophagy | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
DoTc2 4510 | Cervical carcinoma | Homo sapiens | CVCL_1181 | |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 | |
Methyltransferase-like 14 (METTL14) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | DARS-AS1 was validated to facilitate DARS translation via recruiting METTL3 and METTL14, which bound with DARS mRNA Aspartate--tRNA ligase, cytoplasmic (DARS) mRNA 5' untranslated region (5'UTR) and promoting its translation. The present study demonstrated that the 'HIF1-Alpha/DARS-AS1/DARS/ATG5/ATG3' pathway regulated the hypoxia-induced cytoprotective autophagy of cervical cancer(CC) and is a promising target of therapeutic strategies for patients afflicted with CC. | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Pathway Response | Autophagy | hsa04140 | ||
Cell Process | Cell autophagy | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
DoTc2 4510 | Cervical carcinoma | Homo sapiens | CVCL_1181 | |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 | |
Cervical cancer [ICD-11: 2C77]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | DARS-AS1 was validated to facilitate DARS translation via recruiting METTL3 and METTL14, which bound with DARS mRNA Aspartate--tRNA ligase, cytoplasmic (DARS) mRNA 5' untranslated region (5'UTR) and promoting its translation. The present study demonstrated that the 'HIF1-Alpha/DARS-AS1/DARS/ATG5/ATG3' pathway regulated the hypoxia-induced cytoprotective autophagy of cervical cancer(CC) and is a promising target of therapeutic strategies for patients afflicted with CC. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Pathway Response | Autophagy | hsa04140 | ||
Cell Process | Cell autophagy | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
DoTc2 4510 | Cervical carcinoma | Homo sapiens | CVCL_1181 | |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 | |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | DARS-AS1 was validated to facilitate DARS translation via recruiting METTL3 and METTL14, which bound with DARS mRNA Aspartate--tRNA ligase, cytoplasmic (DARS) mRNA 5' untranslated region (5'UTR) and promoting its translation. The present study demonstrated that the 'HIF1-Alpha/DARS-AS1/DARS/ATG5/ATG3' pathway regulated the hypoxia-induced cytoprotective autophagy of cervical cancer(CC) and is a promising target of therapeutic strategies for patients afflicted with CC. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Pathway Response | Autophagy | hsa04140 | ||
Cell Process | Cell autophagy | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
DoTc2 4510 | Cervical carcinoma | Homo sapiens | CVCL_1181 | |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 | |